Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer | MicrobiomeTrials← Back to trialsNCT07195734
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-24Est. Completion: 2033-02-01
Enrollment target: 180 participants Locations- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
- USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Sutter Medical Center Sacramento, Sacramento, California, United States
- Emory Proton Therapy Center, Atlanta, Georgia, United States
- Emory University Hospital Midtown, Atlanta, Georgia, United States
- Rush MD Anderson Cancer Center, Chicago, Illinois, United States
- Rush MD Anderson Cancer Center at Rush Lisle, Lisle, Illinois, United States
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States
- Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, United States
- Iowa Methodist Medical Center, Des Moines, Iowa, United States
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States
- Broadlawns Medical Center, Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines, Des Moines, Iowa, United States
- UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States
- UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States
- University of Kansas Cancer Center, Kansas City, Kansas, United States
- University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
- LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States
- Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States
- University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
- University of Michigan - Brighton Center for Specialty Care, Brighton, Michigan, United States
- Henry Ford Hospital, Detroit, Michigan, United States
- University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States
- University of Kansas Cancer Center - North, Kansas City, Missouri, United States
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States
- Nebraska Methodist Hospital, Omaha, Nebraska, United States
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
- Rutgers New Jersey Medical School, Newark, New Jersey, United States
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- ProMedica Flower Hospital, Sylvania, Ohio, United States
- University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
- Clackamas Radiation Oncology Center, Clackamas, Oregon, United States
- Legacy Mount Hood Medical Center, Gresham, Oregon, United States
- Providence Newberg Medical Center, Newberg, Oregon, United States
- Providence Willamette Falls Medical Center, Oregon City, Oregon, United States
- Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States
- Providence Portland Medical Center, Portland, Oregon, United States
- Providence Saint Vincent Medical Center, Portland, Oregon, United States
- Legacy Meridian Park Hospital, Tualatin, Oregon, United States
- UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States
- UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States
- IRMC Cancer Center, Indiana, Pennsylvania, United States
- UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States
- UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania, United States
- UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States
- Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
- UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
- UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States
- UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States
- UPMC Cancer Center-Washington, Washington, Pennsylvania, United States
- UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States
- Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
- Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver, Washington, United States
- Legacy Salmon Creek Hospital, Vancouver, Washington, United States
- University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek, Wisconsin, United States
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
- Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
- Froedtert and MCW Moorland Reserve Health Center, New Berlin, Wisconsin, United States
- Drexel Town Square Health Center, Oak Creek, Wisconsin, United States
- Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States
Other microbiome trials you might be interested in
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
This phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiatio…
Fairhope, United StatesEst. completion Jan 1, 2027
Basaloid Squamous Cell CarcinomaClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Oropharyngeal Squamous Cell CarcinomaPapillary Squamous Cell CarcinomaPathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Squamous Cell Carcinoma
This phase II/III trial studies how well a reduced dose of radiation therapy works with nivolumab compared to cisplatin …
Birmingham, United StatesEst. completion Mar 1, 2024